Delivery Order SPE2DB24D3015-SPE2DB25FFZTY

Award Date 6/12/25
Potential Completion Date 7/7/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,352.24 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of INGREZZA 40 MG CAPSULE 30S. The ultimate completion date is June 27, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides comprehensive global pharmaceutical support to military healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,553.31, is for the delivery of 4565242920 INGREZZA 40 MG CAPSULE 30S. The contract is a firm fixed-price delivery order with an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $3,119.55 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4563226763 - INGREZZA 40 MG CAPSULE 30S. As a prime contractor, Amerisourcebergen Drug Corp has an indefinite delivery contract with DLA Troop Support Medical to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. This particular delivery order, which has...
This is a $29,785.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 80 mg capsules of the pharmaceutical drug INGREZZA. The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen is a major pharmaceutical distributor to the federal government and holds several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice for the provision of a wide range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $3,714.98 order is for 4,563,358,879 units of the pharmaceutical product INGREZZA 80 MG CAPSULE 30S. The contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp provides pharmaceutical products and services to U.S. government agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 80 MG CAPSULE 30S. The order has a firm fixed price of $3,714.98 and a completion date of February 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,027.70 Firm Fixed Price Delivery Order contract is for the supply of INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,119.55 award is for the delivery of INGREZZA 40 MG CAPSULE 30S pharmaceuticals. As a prime contractor, Amerisourcebergen Drug Corp has provided a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities to support military treatment programs. This delivery order did not utilize any...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $14,213.24 firm fixed price delivery order for 4,564,804,576 units of the pharmaceutical product INGREZZA 40 MG CAPSULE 30S. The contract has an ultimate completion date of June 26, 2024 and was awarded on June 4, 2024 by the Defense Logistics Agency (DLA), a defense agency. The award is associated with Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563518764 INGREZZA 40 MG CAPSULE 30S. The order, valued at $12,478.20, has a completion date of February 23, 2024. Amerisourcebergen Drug Corp also holds a DLA indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFZTY
    Delivery Order

This is a $4,027.70 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency for 4568534681 INGREZZA 80 MG CAPSULE 30S. The order has an ultimate completion date of July 7, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not set-aside.

Generated 9/11/25, 10:54 AM